文献速递儿童血液肿瘤与免疫儿童呼吸

炎症性肿瘤的分子特征促进有效治疗的启动

Molecular Characterization of Inflammatory Tumors Facilitates Initiation of Effective Therapy.
PubMed 文献 · Pediatrics · 2021-01-01

本文报告两例儿童TFG-ROS1融合阳性炎症性肌纤维母细胞瘤(IMT):一例11岁女孩初诊为IgG4相关炎性假瘤,行左全肺切除后复发转移;另一例9岁男孩经快速分子诊断后口服靶向治疗,两例均获良好反应。提示对炎症性肿瘤快速分子检测既助诊断又揭示治疗机会。

要点

  • 儿童炎症性肿瘤症状非特异,易与炎症性疾病混淆而延误诊断。
  • 约85%的IMT携带可靶向的激酶融合,快速分子检测可揭示治疗机会。
  • ROS1融合阳性转移性IMT对口服靶向治疗有显著影像学反应。

核心结论

  • 对炎症性肿瘤进行快速分子检测不仅重要 for 诊断,还揭示治疗机会,靶向抑制剂对ROS1融合IMT产生显著影像学反应。

研究设计与样本

  • 本文为病例报告,报告一例11岁女孩TFG-ROS1融合阳性肺部肿瘤和一例9岁男孩广泛转移性TFG-ROS1融合阳性IMT。

主要发现

  • 11岁女孩初诊为免疫球蛋白G4相关炎性假瘤,行左全肺切除后复发为广泛转移性疾病。
  • 9岁男孩为广泛转移性TFG-ROS1融合阳性IMT,经快速分子诊断。
  • 两名儿童对口服靶向治疗均有极好反应。

关键数值与推荐

  • 约85%的IMT携带可靶向的激酶融合。

临床怎么用

  • 初级保健儿科医生和儿科亚专科医生应尽早咨询有分子诊断经验的儿科肿瘤中心,以促进炎症性肿瘤患儿的全面评估。

局限性

  • 本文为病例报告,样本量小,结论的普适性需进一步研究验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Inflammatory myofibroblastic tumor (IMT) is a rare, mesenchymal tumor that has an increased incidence in childhood. Tumors are usually isolated to the chest, abdomen, and retroperitoneum, but metastatic presentations can be seen. Presenting symptoms are nonspecific and include fever, weight loss, pain, shortness of breath, and cough. Approximately 85% of IMTs harbor actionable kinase fusions. The diagnosis can be delayed because of overlapping features with inflammatory disorders, such as elevated inflammatory markers, increased immunoglobin G levels, fever, weight loss, and morphologic similarity with nonmalignant conditions. We present a girl aged 11 years with a TFG-ROS1 fusion-positive tumor of the lung that was initially diagnosed as an immunoglobin G4-related inflammatory pseudotumor. She underwent complete left-sided pneumonectomy and later recurred with widely metastatic disease. We then report the case of a boy aged 9 years with widely metastatic TFG-ROS1 fusion-positive IMT with rapid molecular diagnosis. In both children, there was an excellent response to oral targeted therapy. These cases reveal that rapid molecular testing of inflammatory tumors is not only important for diagnosis but also reveals therapeutic opportunities. Targeted inhibitors produce significant radiologic responses, enabling potentially curative treatment approaches for metastatic ROS1 fusion IMT with previously limited treatment options. Primary care pediatricians and pediatric subspecialists have a crucial role in the early consultation of a pediatric oncology center experienced in molecular diagnostics to facilitate a comprehensive evaluation for children with inflammatory tumors.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Wachter F, Al-Ibraheemi A, Trissal MC, et al. Molecular Characterization of Inflammatory Tumors Facilitates Initiation of Effective Therapy. Pediatrics. 2021. PMID: 34814185. doi:10.1542/peds.2021-050990

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。